Kiro

Kiro, headquartered in France, is a dynamic startup driving innovation in clinical biology through its adept use of artificial intelligence. With the slogan "Artificial intelligence serving clinical biology," Kiro is committed to enhancing patient care by providing intelligible and relevant data to patients and healthcare professionals.

The company's core belief lies in the critical role of medical biology within healthcare, significantly influencing diagnosis, treatment, and disease prevention. By forging collaborations with clinical biologists and medical experts, Kiro aims to revolutionize medical biology to be more personalized and patient-centric through cutting-edge technology.

Kiro's promising trajectory is supported by a notable €13.80M Series A investment raised on 28 March 2023, backed by established investors including Bpifrance, Kurma Partners, Sofinnova Partners, Propulia Capital, and several business angels. Despite the absence of a specific founding date, Kiro's partnerships and innovative edge position it as a compelling opportunity within the AI and Information Technology sector.